Results: 20

Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort

Objective: The relationship between biomarkers of amyloid-beta aggregation (Aβ1-42) and/or neurodegeneration (Tau protein) in cerebrospinal fluid (CSF) and cognitive decline is still unclear. We aimed to ascertain whether CSF biomarkers correlate with cognitive performance in healthy and cognitively...

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease

Chlorella sorokiniana and Chlorella minutissima exhibit antioxidant potentials, inhibit cholinesterases and modulate disaggregation of β-amyloid fibrils

BACKGROUND: Microalgae are aquatic chlorophyll-containing organisms comprising unicellular microscopic forms, and their biomasses are potential sources of bioactive compounds, biofuels and food-based products. However, the neuroprotective effects of microalgal biomass have not been fully explored. In thi...

Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Colomb. med; 47 (4), 2016
Abstract Alzheimer disease (AD) is the most prevalent form of dementia of adult-onset, characterized by progressive impairment in cognition and memory. There is no cure for the disease and the current treatments are only symptomatic. Drug discovery is an expensive and time-consuming process; in the last ...

Aged Lewis rats exposed to low and moderate doses of rotenone are a good model for studying the process of protein aggregation and its effects upon central nervous system cell physiology

Arq. neuropsiquiatr; 74 (9), 2016
ABSTRACT Cell physiology is impaired before protein aggregation and this may be more relevant than inclusions themselves for neurodegeneration. The present study aimed to characterize an animal model to enable the analysis of the cell biology before and after protein aggregation. Ten-month-old Lewis rats...

Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances

Säo Paulo med. j; 134 (4), 2016
ABSTRACT CONTEXT AND OBJECTIVE: Dementia is a syndrome characterized by functional and cognitive decline. Alzheimer's disease (AD) is one of the most common causes of dementia and has high prevalence among the elderly. It is known that there is no drug capable of interfering with the course of the dise...

Ursolic acid attenuates beta-amyloid-induced memory impairment in mice

Arq. neuropsiquiatr; 74 (6), 2016
ABSTRACT Objective Increasing evidence demonstrates that oxidative stress and inflammatory are involved in amyloid β (Aβ)-induced memory impairments. Ursolic acid (UA), a triterpenoid compound, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether UA atte...

Aspectos da fisiopatologia da doença de Alzheimer esporádica

Rev. bras. neurol; 48 (4), 2012
A doença de Alzheimer (DA) é a forma de demência degenerativa esporádica mais comum. Caracteristicamente ocorre expressiva perda neuronal progressiva em locais específicos nas pessoas atingidas. O distúrbio degenerativo progressivo se caracteriza pela perda de sinapses, de neurônios cerebrais e po...

Uso das estatinas na doença de Alzheimer: uma revisão

HU rev; 36 (3), 2010
A Doença de Alzheimer (DA), caracterizada pela perda da memória e de pelo menos outra função cognitiva, se tornou foco de atenção por parte dos pesquisadores, tendo em vista o aumento de sua prevalência na população mundial. A presença das placas neuríticas, formadas pelo acúmulo do peptídeo...

Neurobiological pathways to Alzheimers disease: Amyloid-beta, Tau protein or both?

Dement. neuropsychol; 3 (3), 2009
Abstract: Alzheimers disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, including memory loss, behavioral and psychological symptoms and personality changes. The neuropathological hallmarks of AD are the presence of neuritic (senile) plaques (NP) and neurofibrilla...